Cargando…

EMT-Induced Stemness and Tumorigenicity Are Fueled by the EGFR/Ras Pathway

Recent studies have revealed that differentiated epithelial cells would acquire stem cell-like and tumorigenic properties following an Epithelial-Mesenchymal Transition (EMT). However, the signaling pathways that participate in this novel mechanism of tumorigenesis have not been fully characterized....

Descripción completa

Detalles Bibliográficos
Autores principales:	Voon, Dominic Chih-Cheng, Wang, Huajing, Koo, Jason Kin Wai, Chai, Juin Hsien, Hor, Yit Teng, Tan, Tuan Zea, Chu, Yeh-Shiu, Mori, Seiichi, Ito, Yoshiaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3741305/ https://www.ncbi.nlm.nih.gov/pubmed/23950932 http://dx.doi.org/10.1371/journal.pone.0070427

Ejemplares similares

A Role for RUNX3 in Inflammation-Induced Expression of IL23A in Gastric Epithelial Cells
por: Hor, Yit Teng, et al.
Publicado: (2014)

HER2 induced EMT and tumorigenicity in breast epithelial progenitor cells is inhibited by coexpression of EGFR
por: Ingthorsson, S, et al.
Publicado: (2016)

Tumorigenicity of RTK/RAS in urothelium
por: Wu, Xue-Ru, et al.
Publicado: (2015)

Metabolomic and Mitochondrial Fingerprinting of the Epithelial-to-Mesenchymal Transition (EMT) in Non-Tumorigenic and Tumorigenic Human Breast Cells
por: Cuyàs, Elisabet, et al.
Publicado: (2022)

The EMT spectrum and therapeutic opportunities
por: Voon, Dominic C., et al.
Publicado: (2017)

RasGRP3, a Ras activator, contributes to signaling and the tumorigenic phenotype in human melanoma
por: Yang, Dazhi, et al.
Publicado: (2011)

Activated K‐ras in Tumorigenic and Non‐tumorigenic Cell Variants from a Rat Colon Adenocarcinoma, Induced by Dimethylhydrazine
por: Caignard, Anne, et al.
Publicado: (1988)

RUNX1 and RUNX3 protect against YAP-mediated EMT, stem-ness and shorter survival outcomes in breast cancer
por: Kulkarni, Madhura, et al.
Publicado: (2018)

Acetylation of KLF5 maintains EMT and tumorigenicity to cause chemoresistant bone metastasis in prostate cancer
por: Zhang, Baotong, et al.
Publicado: (2021)

Phosphorylated EGFR Dimers Are Not Sufficient to Activate Ras
por: Liang, Samantha I., et al.
Publicado: (2018)

Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer
por: Xu, Naiqing, et al.
Publicado: (2015)

Acquired RAS or EGFR mutations and duration of response to EGFR blockade in colorectal cancer
por: Van Emburgh, Beth O., et al.
Publicado: (2016)

LOXL2 Upregulation in Gliomas Drives Tumorigenicity by Activating Autophagy to Promote TMZ Resistance and Trigger EMT
por: Zhang, Qing, et al.
Publicado: (2020)

Specific cancer-associated mutations in the switch III region of Ras increase tumorigenicity by nanocluster augmentation
por: Šolman, Maja, et al.
Publicado: (2015)

Correction: Overexpression of wildtype EGFR is tumorigenic and denotes a therapeutic target in non-small cell lung cancer
por: Xu, Naiqing, et al.
Publicado: (2018)

EGFR Signal-Network Reconstruction Demonstrates Metabolic Crosstalk in EMT
por: Choudhary, Kumari Sonal, et al.
Publicado: (2016)

Current Approaches in NSCLC Targeting K-RAS and EGFR
por: Aran, Veronica, et al.
Publicado: (2019)

Ribosome biogenesis during cell cycle arrest fuels EMT in development and disease
por: Prakash, Varsha, et al.
Publicado: (2019)

Ras Post-transcriptionally Enhances a Pre-malignantly Primed EMT to Promote Invasion
por: Bisogno, Laura S., et al.
Publicado: (2018)

EMT and EGFR in CTCs cytokeratin negative non-metastatic breast cancer
por: Serrano, Maria J., et al.
Publicado: (2014)

Hypoxia Activated EGFR Signaling Induces Epithelial to Mesenchymal Transition (EMT)
por: Misra, Ashish, et al.
Publicado: (2012)

EMT-Mediated Acquired EGFR-TKI Resistance in NSCLC: Mechanisms and Strategies
por: Zhu, Xuan, et al.
Publicado: (2019)

A non-hierarchical organization of tumorigenic NG2 cells in glioblastoma promoted by EGFR
por: Al-Mayhani, Talal F, et al.
Publicado: (2019)

IPO5 Mediates EMT and Promotes Esophageal Cancer Development through the RAS-ERK Pathway
por: Li, Meiyu, et al.
Publicado: (2022)

Myo-Inositol Reverses TGF-β1-Induced EMT in MCF-10A Non-Tumorigenic Breast Cells
por: Monti, Noemi, et al.
Publicado: (2023)

Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120)
por: Huang, Ruby Yun-Ju, et al.
Publicado: (2015)

Ras GAP-related and C-terminal domain-dependent localization and tumorigenic activities of IQGAP1 in melanoma cells
por: Reimer, Michael, et al.
Publicado: (2017)

SNAI1-Driven Sequential EMT Changes Attributed by Selective Chromatin Enrichment of RAD21 and GRHL2
por: Sundararajan, Vignesh, et al.
Publicado: (2020)

EGFR/Ras-induced CCL20 production modulates the tumour microenvironment
por: Hippe, Andreas, et al.
Publicado: (2020)

ECT2 Increases the stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer
por: Wang, Junxiong, et al.
Publicado: (2021)

Tumorigenicity of EGFR- and/or HER2-Positive Breast Cancers Is Mediated by Recruitment of Tumor-Associated Macrophages
por: You, Daeun, et al.
Publicado: (2023)

The H. pylori CagA Oncoprotein Induces DNA Double Strand Breaks through Fanconi Anemia Pathway Downregulation and Replication Fork Collapse
por: Kolinjivadi, Arun Mouli, et al.
Publicado: (2022)

Retraction: ECT2 Increases the Stability of EGFR and Tumorigenicity by Inhibiting Grb2 Ubiquitination in Pancreatic Cancer
Publicado: (2021)

CD109 Is a Critical Determinant of EGFR Expression and Signaling, and Tumorigenicity in Squamous Cell Carcinoma Cells
por: Zhou, Shufeng, et al.
Publicado: (2022)

Semaphorin-7a reverses the ERF-induced inhibition of EMT in Ras-dependent mouse mammary epithelial cells
por: Allegra, Maryline, et al.
Publicado: (2012)

Dynamics of chromatin accessibility during TGF-β-induced EMT of Ras-transformed mammary gland epithelial cells
por: Arase, Mayu, et al.
Publicado: (2017)

Anti-tumorigenic and Pro-apoptotic effects of CKBM on gastric cancer growth in nude mice
por: Shin, Vivian Yvonne, et al.
Publicado: (2004)

Uncoupling of EGFR–RAS signaling and nuclear localization of YBX1 in colorectal cancer
por: Roßner, F, et al.
Publicado: (2016)

EGFR-RAS-MAPK signaling is confined to the plasma membrane and associated endorecycling protrusions
por: Surve, Sachin, et al.
Publicado: (2021)

CYTOPLASMIC-MEMBRANE EGFR PREDICTS EXPANDED RAS MUTATION STATUS IN COLORECTAL CARCINOMAS?
por: PINTO, Thiago David Alves, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_cbf0ip50rtt0km8vmugfqkm110